Compile Data Set for Download or QSAR

Found 176 hits with Last Name = 'sakata' and Initial = 'y'   

Target/Host (Institution)	Ligand	Target/Host Links	Ligand Links	Trg + Lig Links	Ki nM	ΔG° kJ/mole	IC50 nM	Kd nM	EC50/IC50 nM	koff s-1	kon M-1s-1	pH	Temp °C
Beta-galactosidase (Bos taurus (Bovine))	BDBM50133507 (4-Decylamino-6-methyl-cyclohexane-1,2,3-triol | CH...) Show SMILES CCCCCCCCCCNC1CC(C)C(O)C(O)C1O Show InChI InChI=1S/C17H35NO3/c1-3-4-5-6-7-8-9-10-11-18-14-12-13(2)15(19)17(21)16(14)20/h13-21H,3-12H2,1-2H3	KEGG UniProtKB/SwissProt GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	PubMed	9	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Keio University Curated by ChEMBL					Assay Description Inhibitory activity of the compound against beta-galactosidase in bovine liver				Bioorg Med Chem Lett 13: 3461-3 (2003) BindingDB Entry DOI: 10.7270/Q2FF3RR7
					More data for this Ligand-Target Pair
Tissue alpha-L-fucosidase (Homo sapiens (Human))	BDBM50118923 ((1S,2S,3R)-4-Methyl-6-octylamino-cyclohexane-1,2,3...) Show SMILES CCCCCCCCNC1CC(C)C(O)C(O)C1O Show InChI InChI=1S/C15H31NO3/c1-3-4-5-6-7-8-9-16-12-10-11(2)13(17)15(19)14(12)18/h11-19H,3-10H2,1-2H3	PDB KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	PubMed	16	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Keio University Curated by ChEMBL					Assay Description Binding affinity against alpha-L-fucosidase in bovine kidney was determined				Bioorg Med Chem Lett 12: 2811-4 (2002) BindingDB Entry DOI: 10.7270/Q2C24WZJ
					More data for this Ligand-Target Pair
Tissue alpha-L-fucosidase (Homo sapiens (Human))	BDBM50065258 ((2S,3R,4S,5R)-2-Methyl-piperidine-3,4,5-triol | (2...) Show SMILES C[C@@H]1NC[C@@H](O)[C@H](O)[C@@H]1O Show InChI InChI=1S/C6H13NO3/c1-3-5(9)6(10)4(8)2-7-3/h3-10H,2H2,1H3/t3-,4+,5+,6-/m0/s1	PDB KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	Purchase CHEMBL MCE MMDB PC cid PC sid PDB UniChem Patents Similars	PDB PubMed	31	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Keio University Curated by ChEMBL					Assay Description Binding affinity against alpha-L-fucosidase in bovine kidney was determined				Bioorg Med Chem Lett 12: 2811-4 (2002) BindingDB Entry DOI: 10.7270/Q2C24WZJ
					More data for this Ligand-Target Pair				3D Structure (crystal)
Tissue alpha-L-fucosidase (Homo sapiens (Human))	BDBM50118928 ((1S,2S,3R)-4-Methyl-6-phenethylamino-cyclohexane-1...) Show SMILES CC1CC(NCCc2ccccc2)C(O)C(O)C1O Show InChI InChI=1S/C15H23NO3/c1-10-9-12(14(18)15(19)13(10)17)16-8-7-11-5-3-2-4-6-11/h2-6,10,12-19H,7-9H2,1H3	PDB KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	PubMed	32	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Keio University Curated by ChEMBL					Assay Description Binding affinity against alpha-L-fucosidase in bovine kidney was determined				Bioorg Med Chem Lett 12: 2811-4 (2002) BindingDB Entry DOI: 10.7270/Q2C24WZJ
					More data for this Ligand-Target Pair
Beta-galactosidase (Bos taurus (Bovine))	BDBM50133504 (4-Methyl-6-(4-phenyl-butylamino)-cyclohexane-1,2,3...) Show SMILES CC1CC(NCCCCc2ccccc2)C(O)C(O)C1O Show InChI InChI=1S/C17H27NO3/c1-12-11-14(16(20)17(21)15(12)19)18-10-6-5-9-13-7-3-2-4-8-13/h2-4,7-8,12,14-21H,5-6,9-11H2,1H3	KEGG UniProtKB/SwissProt GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	PubMed	46	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Keio University Curated by ChEMBL					Assay Description Inhibitory activity of the compound against beta-galactosidase in bovine liver				Bioorg Med Chem Lett 13: 3461-3 (2003) BindingDB Entry DOI: 10.7270/Q2FF3RR7
					More data for this Ligand-Target Pair
Tissue alpha-L-fucosidase (Homo sapiens (Human))	BDBM50118921 ((1R,2S,3S)-4-Heptylamino-6-methyl-cyclohexane-1,2,...) Show SMILES CCCCCCCNC1CC(C)C(O)C(O)C1O Show InChI InChI=1S/C14H29NO3/c1-3-4-5-6-7-8-15-11-9-10(2)12(16)14(18)13(11)17/h10-18H,3-9H2,1-2H3	PDB KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	PubMed	48	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Keio University Curated by ChEMBL					Assay Description Binding affinity against alpha-L-fucosidase in bovine kidney was determined				Bioorg Med Chem Lett 12: 2811-4 (2002) BindingDB Entry DOI: 10.7270/Q2C24WZJ
					More data for this Ligand-Target Pair
Tissue alpha-L-fucosidase (Homo sapiens (Human))	BDBM50118920 ((1R,2S,3S)-4-Benzylamino-6-methyl-cyclohexane-1,2,...) Show SMILES CC1CC(NCc2ccccc2)C(O)C(O)C1O Show InChI InChI=1S/C14H21NO3/c1-9-7-11(13(17)14(18)12(9)16)15-8-10-5-3-2-4-6-10/h2-6,9,11-18H,7-8H2,1H3	PDB KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	PubMed	69	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Keio University Curated by ChEMBL					Assay Description Binding affinity against alpha-L-fucosidase in bovine kidney was determined				Bioorg Med Chem Lett 12: 2811-4 (2002) BindingDB Entry DOI: 10.7270/Q2C24WZJ
					More data for this Ligand-Target Pair
Tissue alpha-L-fucosidase (Homo sapiens (Human))	BDBM50118922 ((1R,2S,3S)-4-Butylamino-6-methyl-cyclohexane-1,2,3...) Show SMILES CCCCNC1CC(C)C(O)C(O)C1O Show InChI InChI=1S/C11H23NO3/c1-3-4-5-12-8-6-7(2)9(13)11(15)10(8)14/h7-15H,3-6H2,1-2H3	PDB KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	PubMed	74	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Keio University Curated by ChEMBL					Assay Description Binding affinity against alpha-L-fucosidase in bovine kidney was determined				Bioorg Med Chem Lett 12: 2811-4 (2002) BindingDB Entry DOI: 10.7270/Q2C24WZJ
					More data for this Ligand-Target Pair
Tissue alpha-L-fucosidase (Homo sapiens (Human))	BDBM50118919 ((1S,2S,3R)-4-Methyl-6-nonylamino-cyclohexane-1,2,3...) Show SMILES CCCCCCCCCNC1CC(C)C(O)C(O)C1O Show InChI InChI=1S/C16H33NO3/c1-3-4-5-6-7-8-9-10-17-13-11-12(2)14(18)16(20)15(13)19/h12-20H,3-11H2,1-2H3	PDB KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	PubMed	110	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Keio University Curated by ChEMBL					Assay Description Binding affinity against alpha-L-fucosidase in bovine kidney was determined				Bioorg Med Chem Lett 12: 2811-4 (2002) BindingDB Entry DOI: 10.7270/Q2C24WZJ
					More data for this Ligand-Target Pair
Beta-galactosidase (Bos taurus (Bovine))	BDBM50118923 ((1S,2S,3R)-4-Methyl-6-octylamino-cyclohexane-1,2,3...) Show SMILES CCCCCCCCNC1CC(C)C(O)C(O)C1O Show InChI InChI=1S/C15H31NO3/c1-3-4-5-6-7-8-9-16-12-10-11(2)13(17)15(19)14(12)18/h11-19H,3-10H2,1-2H3	KEGG UniProtKB/SwissProt GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	PubMed	110	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Keio University Curated by ChEMBL					Assay Description Inhibitory activity of the compound against beta-galactosidase in bovine liver				Bioorg Med Chem Lett 13: 3461-3 (2003) BindingDB Entry DOI: 10.7270/Q2FF3RR7
					More data for this Ligand-Target Pair
Tissue alpha-L-fucosidase (Homo sapiens (Human))	BDBM50118926 ((1R,2S,3S)-4-Ethylamino-6-methyl-cyclohexane-1,2,3...) Show SMILES CCNC1CC(C)C(O)C(O)C1O Show InChI InChI=1S/C9H19NO3/c1-3-10-6-4-5(2)7(11)9(13)8(6)12/h5-13H,3-4H2,1-2H3	PDB KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	PubMed	180	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Keio University Curated by ChEMBL					Assay Description Binding affinity against alpha-L-fucosidase in bovine kidney was determined				Bioorg Med Chem Lett 12: 2811-4 (2002) BindingDB Entry DOI: 10.7270/Q2C24WZJ
					More data for this Ligand-Target Pair
Tissue alpha-L-fucosidase (Homo sapiens (Human))	BDBM50403994 (CHEMBL2114287) Show SMILES C[C@@H]1C[C@@H](N)[C@@H](O)[C@H](O)[C@@H]1O |r| Show InChI InChI=1S/C7H15NO3/c1-3-2-4(8)6(10)7(11)5(3)9/h3-7,9-11H,2,8H2,1H3/t3-,4-,5-,6-,7-/m1/s1	PDB KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	PubMed	1.00E+3	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Keio University Curated by ChEMBL					Assay Description Binding affinity against alpha-L-fucosidase in bovine kidney was determined				Bioorg Med Chem Lett 12: 2811-4 (2002) BindingDB Entry DOI: 10.7270/Q2C24WZJ
					More data for this Ligand-Target Pair
Tissue alpha-L-fucosidase (Homo sapiens (Human))	BDBM50403995 (CHEMBL2115269) Show SMILES C[C@@H]1C[C@H](N)[C@@H](O)[C@H](O)[C@@H]1O |r| Show InChI InChI=1S/C7H15NO3/c1-3-2-4(8)6(10)7(11)5(3)9/h3-7,9-11H,2,8H2,1H3/t3-,4+,5-,6-,7-/m1/s1	PDB KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	PubMed	2.90E+3	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Keio University Curated by ChEMBL					Assay Description Binding affinity against alpha-L-fucosidase in bovine kidney was determined				Bioorg Med Chem Lett 12: 2811-4 (2002) BindingDB Entry DOI: 10.7270/Q2C24WZJ
					More data for this Ligand-Target Pair
Neuropeptide Y receptor type 5 (Homo sapiens (Human))	BDBM50111656 (1-[2-(5-Chloro-2-oxo-benzothiazol-3-yl)-acetyl]-pi...) Show SMILES Clc1ccc2sc(=O)n(CC(=O)N3CCC(CC3)C(=O)Nc3ccc(Cl)c4ccccc34)c2c1 Show InChI InChI=1S/C25H21Cl2N3O3S/c26-16-5-8-22-21(13-16)30(25(33)34-22)14-23(31)29-11-9-15(10-12-29)24(32)28-20-7-6-19(27)17-3-1-2-4-18(17)20/h1-8,13,15H,9-12,14H2,(H,28,32)	KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	PubMed	n/a	n/a	0.230	n/a	n/a	n/a	n/a	n/a	n/a
Fujisawa Pharmaceutical Co., Ltd. Curated by ChEMBL					Assay Description Tested for the inhibition of [125I]-PYY binding to HEK 293 cells stably expressed with human neuropeptide NPY Y5 receptor				Bioorg Med Chem Lett 12: 1171-5 (2002) BindingDB Entry DOI: 10.7270/Q26M365J
					More data for this Ligand-Target Pair
Neuropeptide Y receptor type 5 (Homo sapiens (Human))	BDBM50110571 (CHEMBL167991 | FR-230481 | Naphthalene-1-sulfonic ...) Show SMILES COc1ccc2CCCC(O)(CNCC3CCN(CCNS(=O)(=O)c4cccc5ccccc45)CC3)c2c1 Show InChI InChI=1S/C30H39N3O4S/c1-37-26-12-11-25-8-5-15-30(34,28(25)20-26)22-31-21-23-13-17-33(18-14-23)19-16-32-38(35,36)29-10-4-7-24-6-2-3-9-27(24)29/h2-4,6-7,9-12,20,23,31-32,34H,5,8,13-19,21-22H2,1H3	KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	PubMed	n/a	n/a	0.540	n/a	n/a	n/a	n/a	n/a	n/a
Fujisawa Pharmaceutical Co., Ltd. Curated by ChEMBL					Assay Description Inhibition of 125 I-PYY binding to human Neuropeptide Y receptor type 5				Bioorg Med Chem Lett 12: 799-802 (2002) BindingDB Entry DOI: 10.7270/Q2M044R7
					More data for this Ligand-Target Pair
Neuropeptide Y receptor type 5 (Homo sapiens (Human))	BDBM50111644 (1-[2-(5-Chloro-2-oxo-benzothiazol-3-yl)-acetyl]-pi...) Show SMILES CC(=O)c1cccc(NC(=O)C2CCN(CC2)C(=O)Cn2c3cc(Cl)ccc3sc2=O)c1 Show InChI InChI=1S/C23H22ClN3O4S/c1-14(28)16-3-2-4-18(11-16)25-22(30)15-7-9-26(10-8-15)21(29)13-27-19-12-17(24)5-6-20(19)32-23(27)31/h2-6,11-12,15H,7-10,13H2,1H3,(H,25,30)	KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	PubMed	n/a	n/a	0.590	n/a	n/a	n/a	n/a	n/a	n/a
Fujisawa Pharmaceutical Co., Ltd. Curated by ChEMBL					Assay Description Inhibitory concentration of total specific binding of [125I]- -PYY to HEK 293 cells transfected with the Human NPY-Y5 cDNA (compound prepared by para...				Bioorg Med Chem Lett 12: 1171-5 (2002) BindingDB Entry DOI: 10.7270/Q26M365J
					More data for this Ligand-Target Pair
Neuropeptide Y receptor type 5 (Homo sapiens (Human))	BDBM50111645 (1-[2-(5-Chloro-2-oxo-benzothiazol-3-yl)-acetyl]-pi...) Show SMILES Fc1ccc(NC(=O)C2CCN(CC2)C(=O)Cn2c3cc(Cl)ccc3sc2=O)cc1C(F)(F)F Show InChI InChI=1S/C22H18ClF4N3O3S/c23-13-1-4-18-17(9-13)30(21(33)34-18)11-19(31)29-7-5-12(6-8-29)20(32)28-14-2-3-16(24)15(10-14)22(25,26)27/h1-4,9-10,12H,5-8,11H2,(H,28,32)	KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	PubMed	n/a	n/a	0.590	n/a	n/a	n/a	n/a	n/a	n/a
Fujisawa Pharmaceutical Co., Ltd. Curated by ChEMBL					Assay Description Inhibitory concentration of total specific binding of [125I]- -PYY to HEK 293 cells transfected with Human NPY-Y5 cDNA (compound prepared by manual s...				Bioorg Med Chem Lett 12: 1171-5 (2002) BindingDB Entry DOI: 10.7270/Q26M365J
					More data for this Ligand-Target Pair
Neuropeptide Y receptor type 5 (Homo sapiens (Human))	BDBM50111645 (1-[2-(5-Chloro-2-oxo-benzothiazol-3-yl)-acetyl]-pi...) Show SMILES Fc1ccc(NC(=O)C2CCN(CC2)C(=O)Cn2c3cc(Cl)ccc3sc2=O)cc1C(F)(F)F Show InChI InChI=1S/C22H18ClF4N3O3S/c23-13-1-4-18-17(9-13)30(21(33)34-18)11-19(31)29-7-5-12(6-8-29)20(32)28-14-2-3-16(24)15(10-14)22(25,26)27/h1-4,9-10,12H,5-8,11H2,(H,28,32)	KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	PubMed	n/a	n/a	0.700	n/a	n/a	n/a	n/a	n/a	n/a
Fujisawa Pharmaceutical Co., Ltd. Curated by ChEMBL					Assay Description Inhibitory concentration of total specific binding of [125I]- -PYY to HEK 293 cells transfected with the Human NPY-Y5 cDNA (compound prepared by para...				Bioorg Med Chem Lett 12: 1171-5 (2002) BindingDB Entry DOI: 10.7270/Q26M365J
					More data for this Ligand-Target Pair
Neuropeptide Y receptor type 5 (Homo sapiens (Human))	BDBM50110562 (5-Chloro-3-(2-{4-[(3-methoxy-6,7,8,9-tetrahydro-5H...) Show SMILES COc1ccc2CCCC(Cc2c1)NCC1CCN(CC1)C(=O)Cn1c2cc(Cl)ccc2sc1=O Show InChI InChI=1S/C27H32ClN3O3S/c1-34-23-7-5-19-3-2-4-22(13-20(19)14-23)29-16-18-9-11-30(12-10-18)26(32)17-31-24-15-21(28)6-8-25(24)35-27(31)33/h5-8,14-15,18,22,29H,2-4,9-13,16-17H2,1H3	KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	PubMed	n/a	n/a	0.700	n/a	n/a	n/a	n/a	n/a	n/a
Fujisawa Pharmaceutical Co., Ltd. Curated by ChEMBL					Assay Description Inhibition of 125 I-PYY binding to human Neuropeptide Y receptor type 5				Bioorg Med Chem Lett 12: 799-802 (2002) BindingDB Entry DOI: 10.7270/Q2M044R7
					More data for this Ligand-Target Pair
Neuropeptide Y receptor type 5 (Homo sapiens (Human))	BDBM50111646 (1-[2-(5-Chloro-2-oxo-benzothiazol-3-yl)-acetyl]-pi...) Show SMILES Clc1ccc2sc(=O)n(CC(=O)N3CCC(CC3)C(=O)Nc3cccc4ccccc34)c2c1 Show InChI InChI=1S/C25H22ClN3O3S/c26-18-8-9-22-21(14-18)29(25(32)33-22)15-23(30)28-12-10-17(11-13-28)24(31)27-20-7-3-5-16-4-1-2-6-19(16)20/h1-9,14,17H,10-13,15H2,(H,27,31)	KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	PubMed	n/a	n/a	0.710	n/a	n/a	n/a	n/a	n/a	n/a
Fujisawa Pharmaceutical Co., Ltd. Curated by ChEMBL					Assay Description Inhibitory concentration of total specific binding of [125I]- -PYY to HEK 293 cells transfected with the Human NPY-Y5 cDNA (compound prepared by para...				Bioorg Med Chem Lett 12: 1171-5 (2002) BindingDB Entry DOI: 10.7270/Q26M365J
					More data for this Ligand-Target Pair
Neuropeptide Y receptor type 5 (Homo sapiens (Human))	BDBM50111647 (1-[2-(5-Chloro-2-oxo-benzothiazol-3-yl)-acetyl]-pi...) Show SMILES Clc1ccc2sc(=O)n(CC(=O)N3CCC(CC3)C(=O)Nc3ccc(Oc4ccccc4)cc3)c2c1 Show InChI InChI=1S/C27H24ClN3O4S/c28-19-6-11-24-23(16-19)31(27(34)36-24)17-25(32)30-14-12-18(13-15-30)26(33)29-20-7-9-22(10-8-20)35-21-4-2-1-3-5-21/h1-11,16,18H,12-15,17H2,(H,29,33)	KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	PubMed	n/a	n/a	0.850	n/a	n/a	n/a	n/a	n/a	n/a
Fujisawa Pharmaceutical Co., Ltd. Curated by ChEMBL					Assay Description Inhibitory concentration of total specific binding of [125I]- -PYY to HEK 293 cells transfected with the Human NPY-Y5 cDNA (compound prepared by para...				Bioorg Med Chem Lett 12: 1171-5 (2002) BindingDB Entry DOI: 10.7270/Q26M365J
					More data for this Ligand-Target Pair
Neuropeptide Y receptor type 5 (Homo sapiens (Human))	BDBM50111641 (1-[2-(5-Chloro-2-oxo-benzothiazol-3-yl)-acetyl]-pi...) Show SMILES Clc1ccc2sc(=O)n(CC(=O)N3CCC(CC3)C(=O)Nc3cccc(c3)C(=O)c3ccccc3)c2c1 Show InChI InChI=1S/C28H24ClN3O4S/c29-21-9-10-24-23(16-21)32(28(36)37-24)17-25(33)31-13-11-19(12-14-31)27(35)30-22-8-4-7-20(15-22)26(34)18-5-2-1-3-6-18/h1-10,15-16,19H,11-14,17H2,(H,30,35)	KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	PubMed	n/a	n/a	0.890	n/a	n/a	n/a	n/a	n/a	n/a
Fujisawa Pharmaceutical Co., Ltd. Curated by ChEMBL					Assay Description Inhibitory concentration of total specific binding of [125I]- -PYY to HEK 293 cells transfected with Human NPY-Y5 cDNA (compound prepared by manual s...				Bioorg Med Chem Lett 12: 1171-5 (2002) BindingDB Entry DOI: 10.7270/Q26M365J
					More data for this Ligand-Target Pair
Neuropeptide Y receptor type 5 (Homo sapiens (Human))	BDBM50110567 (1-[2-(5-Chloro-2-oxo-benzothiazol-3-yl)-acetyl]-pi...) Show SMILES COc1ccc2CCCC(O)(CNC(=O)C3CCN(CC3)C(=O)Cn3c4cc(Cl)ccc4sc3=O)c2c1 Show InChI InChI=1S/C27H30ClN3O5S/c1-36-20-6-4-17-3-2-10-27(35,21(17)14-20)16-29-25(33)18-8-11-30(12-9-18)24(32)15-31-22-13-19(28)5-7-23(22)37-26(31)34/h4-7,13-14,18,35H,2-3,8-12,15-16H2,1H3,(H,29,33)	KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	PubMed	n/a	n/a	1	n/a	n/a	n/a	n/a	n/a	n/a
Fujisawa Pharmaceutical Co., Ltd. Curated by ChEMBL					Assay Description Inhibition of 125 I-PYY binding to human Neuropeptide Y receptor type 5				Bioorg Med Chem Lett 12: 799-802 (2002) BindingDB Entry DOI: 10.7270/Q2M044R7
					More data for this Ligand-Target Pair
Neuropeptide Y receptor type 5 (Homo sapiens (Human))	BDBM50111650 (1-[2-(5-Chloro-2-oxo-benzothiazol-3-yl)-acetyl]-pi...) Show SMILES OC(CNC(=O)C1CCN(CC1)C(=O)Cn1c2cc(Cl)ccc2sc1=O)c1ccccc1 Show InChI InChI=1S/C23H24ClN3O4S/c24-17-6-7-20-18(12-17)27(23(31)32-20)14-21(29)26-10-8-16(9-11-26)22(30)25-13-19(28)15-4-2-1-3-5-15/h1-7,12,16,19,28H,8-11,13-14H2,(H,25,30)	KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	PubMed	n/a	n/a	1.10	n/a	n/a	n/a	n/a	n/a	n/a
Fujisawa Pharmaceutical Co., Ltd. Curated by ChEMBL					Assay Description Inhibitory concentration of total specific binding of [125I]- -PYY to HEK 293 cells transfected with the Human NPY-Y5 cDNA (compound prepared by para...				Bioorg Med Chem Lett 12: 1171-5 (2002) BindingDB Entry DOI: 10.7270/Q26M365J
					More data for this Ligand-Target Pair
Neuropeptide Y receptor type 5 (Homo sapiens (Human))	BDBM50111650 (1-[2-(5-Chloro-2-oxo-benzothiazol-3-yl)-acetyl]-pi...) Show SMILES OC(CNC(=O)C1CCN(CC1)C(=O)Cn1c2cc(Cl)ccc2sc1=O)c1ccccc1 Show InChI InChI=1S/C23H24ClN3O4S/c24-17-6-7-20-18(12-17)27(23(31)32-20)14-21(29)26-10-8-16(9-11-26)22(30)25-13-19(28)15-4-2-1-3-5-15/h1-7,12,16,19,28H,8-11,13-14H2,(H,25,30)	KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	PubMed	n/a	n/a	1.20	n/a	n/a	n/a	n/a	n/a	n/a
Fujisawa Pharmaceutical Co., Ltd. Curated by ChEMBL					Assay Description Inhibitory concentration of total specific binding of [125I]- -PYY to HEK 293 cells transfected with Human NPY-Y5 cDNA (compound prepared by manual s...				Bioorg Med Chem Lett 12: 1171-5 (2002) BindingDB Entry DOI: 10.7270/Q26M365J
					More data for this Ligand-Target Pair
Neuropeptide Y receptor type 5 (Homo sapiens (Human))	BDBM50110569 (1-[2-(5-Chloro-2-oxo-benzothiazol-3-yl)-acetyl]-pi...) Show SMILES COc1ccc2CCCC(CNC(=O)C3CCN(CC3)C(=O)Cn3c4cc(Cl)ccc4sc3=O)Cc2c1 Show InChI InChI=1S/C28H32ClN3O4S/c1-36-23-7-5-19-4-2-3-18(13-21(19)14-23)16-30-27(34)20-9-11-31(12-10-20)26(33)17-32-24-15-22(29)6-8-25(24)37-28(32)35/h5-8,14-15,18,20H,2-4,9-13,16-17H2,1H3,(H,30,34)	KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	PubMed	n/a	n/a	1.20	n/a	n/a	n/a	n/a	n/a	n/a
Fujisawa Pharmaceutical Co., Ltd. Curated by ChEMBL					Assay Description Inhibition of 125 I-PYY binding to human Neuropeptide Y receptor type 5				Bioorg Med Chem Lett 12: 799-802 (2002) BindingDB Entry DOI: 10.7270/Q2M044R7
					More data for this Ligand-Target Pair
Neuropeptide Y receptor type 5 (Homo sapiens (Human))	BDBM50111649 (1-[2-(5-Chloro-2-oxo-benzothiazol-3-yl)-acetyl]-pi...) Show SMILES CCCCCCCCCCNC(=O)C1CCN(CC1)C(=O)Cn1c2cc(Cl)ccc2sc1=O Show InChI InChI=1S/C25H36ClN3O3S/c1-2-3-4-5-6-7-8-9-14-27-24(31)19-12-15-28(16-13-19)23(30)18-29-21-17-20(26)10-11-22(21)33-25(29)32/h10-11,17,19H,2-9,12-16,18H2,1H3,(H,27,31)	KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	PubMed	n/a	n/a	1.30	n/a	n/a	n/a	n/a	n/a	n/a
Fujisawa Pharmaceutical Co., Ltd. Curated by ChEMBL					Assay Description Inhibitory concentration of total specific binding of [125I]- -PYY to HEK 293 cells transfected with Human NPY-Y5 cDNA (compound prepared by manual s...				Bioorg Med Chem Lett 12: 1171-5 (2002) BindingDB Entry DOI: 10.7270/Q26M365J
					More data for this Ligand-Target Pair
Neuropeptide Y receptor type 5 (Homo sapiens (Human))	BDBM50111654 (1-[2-(5-Chloro-2-oxo-benzothiazol-3-yl)-acetyl]-pi...) Show SMILES COc1ccc(CNC(=O)C2CCN(CC2)C(=O)Cn2c3cc(Cl)ccc3sc2=O)cc1 Show InChI InChI=1S/C23H24ClN3O4S/c1-31-18-5-2-15(3-6-18)13-25-22(29)16-8-10-26(11-9-16)21(28)14-27-19-12-17(24)4-7-20(19)32-23(27)30/h2-7,12,16H,8-11,13-14H2,1H3,(H,25,29)	KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	PubMed	n/a	n/a	1.40	n/a	n/a	n/a	n/a	n/a	n/a
Fujisawa Pharmaceutical Co., Ltd. Curated by ChEMBL					Assay Description Inhibitory concentration of total specific binding of [125I]- -PYY to HEK 293 cells transfected with the Human NPY-Y5 cDNA (compound prepared by para...				Bioorg Med Chem Lett 12: 1171-5 (2002) BindingDB Entry DOI: 10.7270/Q26M365J
					More data for this Ligand-Target Pair
Neuropeptide Y receptor type 5 (Homo sapiens (Human))	BDBM50111641 (1-[2-(5-Chloro-2-oxo-benzothiazol-3-yl)-acetyl]-pi...) Show SMILES Clc1ccc2sc(=O)n(CC(=O)N3CCC(CC3)C(=O)Nc3cccc(c3)C(=O)c3ccccc3)c2c1 Show InChI InChI=1S/C28H24ClN3O4S/c29-21-9-10-24-23(16-21)32(28(36)37-24)17-25(33)31-13-11-19(12-14-31)27(35)30-22-8-4-7-20(15-22)26(34)18-5-2-1-3-6-18/h1-10,15-16,19H,11-14,17H2,(H,30,35)	KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	PubMed	n/a	n/a	1.40	n/a	n/a	n/a	n/a	n/a	n/a
Fujisawa Pharmaceutical Co., Ltd. Curated by ChEMBL					Assay Description Inhibitory concentration of total specific binding of [125I]- -PYY to HEK 293 cells transfected with Human NPY-Y5 cDNA (compound prepared by manual s...				Bioorg Med Chem Lett 12: 1171-5 (2002) BindingDB Entry DOI: 10.7270/Q26M365J
					More data for this Ligand-Target Pair
Neuropeptide Y receptor type 5 (Homo sapiens (Human))	BDBM50111651 (1-[2-(5-Chloro-2-oxo-benzothiazol-3-yl)-acetyl]-pi...) Show SMILES Cc1cc(O)ccc1NC(=O)C1CCN(CC1)C(=O)Cn1c2cc(Cl)ccc2sc1=O Show InChI InChI=1S/C22H22ClN3O4S/c1-13-10-16(27)3-4-17(13)24-21(29)14-6-8-25(9-7-14)20(28)12-26-18-11-15(23)2-5-19(18)31-22(26)30/h2-5,10-11,14,27H,6-9,12H2,1H3,(H,24,29)	KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	PubMed	n/a	n/a	1.40	n/a	n/a	n/a	n/a	n/a	n/a
Fujisawa Pharmaceutical Co., Ltd. Curated by ChEMBL					Assay Description Inhibitory concentration of total specific binding of [125I]- -PYY to HEK 293 cells transfected with Human NPY-Y5 cDNA (compound prepared by manual s...				Bioorg Med Chem Lett 12: 1171-5 (2002) BindingDB Entry DOI: 10.7270/Q26M365J
					More data for this Ligand-Target Pair
Neuropeptide Y receptor type 5 (Homo sapiens (Human))	BDBM50111647 (1-[2-(5-Chloro-2-oxo-benzothiazol-3-yl)-acetyl]-pi...) Show SMILES Clc1ccc2sc(=O)n(CC(=O)N3CCC(CC3)C(=O)Nc3ccc(Oc4ccccc4)cc3)c2c1 Show InChI InChI=1S/C27H24ClN3O4S/c28-19-6-11-24-23(16-19)31(27(34)36-24)17-25(32)30-14-12-18(13-15-30)26(33)29-20-7-9-22(10-8-20)35-21-4-2-1-3-5-21/h1-11,16,18H,12-15,17H2,(H,29,33)	KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	PubMed	n/a	n/a	1.5	n/a	n/a	n/a	n/a	n/a	n/a
Fujisawa Pharmaceutical Co., Ltd. Curated by ChEMBL					Assay Description Inhibitory concentration of total specific binding of [125I]- -PYY to HEK 293 cells transfected with the Human NPY-Y5 cDNA (compound prepared by para...				Bioorg Med Chem Lett 12: 1171-5 (2002) BindingDB Entry DOI: 10.7270/Q26M365J
					More data for this Ligand-Target Pair
Neuropeptide Y receptor type 5 (Homo sapiens (Human))	BDBM50111643 (1-[2-(5-Chloro-2-oxo-benzothiazol-3-yl)-acetyl]-pi...) Show SMILES OCCc1ccc(NC(=O)C2CCN(CC2)C(=O)Cn2c3cc(Cl)ccc3sc2=O)cc1 Show InChI InChI=1S/C23H24ClN3O4S/c24-17-3-6-20-19(13-17)27(23(31)32-20)14-21(29)26-10-7-16(8-11-26)22(30)25-18-4-1-15(2-5-18)9-12-28/h1-6,13,16,28H,7-12,14H2,(H,25,30)	KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	PubMed	n/a	n/a	1.70	n/a	n/a	n/a	n/a	n/a	n/a
Fujisawa Pharmaceutical Co., Ltd. Curated by ChEMBL					Assay Description Inhibitory concentration of total specific binding of [125I]- -PYY to HEK 293 cells transfected with Human NPY-Y5 cDNA (compound prepared by manual s...				Bioorg Med Chem Lett 12: 1171-5 (2002) BindingDB Entry DOI: 10.7270/Q26M365J
					More data for this Ligand-Target Pair
Neuropeptide Y receptor type 5 (Homo sapiens (Human))	BDBM50111644 (1-[2-(5-Chloro-2-oxo-benzothiazol-3-yl)-acetyl]-pi...) Show SMILES CC(=O)c1cccc(NC(=O)C2CCN(CC2)C(=O)Cn2c3cc(Cl)ccc3sc2=O)c1 Show InChI InChI=1S/C23H22ClN3O4S/c1-14(28)16-3-2-4-18(11-16)25-22(30)15-7-9-26(10-8-15)21(29)13-27-19-12-17(24)5-6-20(19)32-23(27)31/h2-6,11-12,15H,7-10,13H2,1H3,(H,25,30)	KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	PubMed	n/a	n/a	2	n/a	n/a	n/a	n/a	n/a	n/a
Fujisawa Pharmaceutical Co., Ltd. Curated by ChEMBL					Assay Description Inhibitory concentration of total specific binding of [125I]- -PYY to HEK 293 cells transfected with the Human NPY-Y5 cDNA (compound prepared by para...				Bioorg Med Chem Lett 12: 1171-5 (2002) BindingDB Entry DOI: 10.7270/Q26M365J
					More data for this Ligand-Target Pair
Neuropeptide Y receptor type 5 (Homo sapiens (Human))	BDBM50111642 (1-[2-(5-Chloro-2-oxo-benzothiazol-3-yl)-acetyl]-pi...) Show SMILES COc1ccc(NC(=O)C2CCN(CC2)C(=O)Cn2c3cc(Cl)ccc3sc2=O)cn1 Show InChI InChI=1S/C21H21ClN4O4S/c1-30-18-5-3-15(11-23-18)24-20(28)13-6-8-25(9-7-13)19(27)12-26-16-10-14(22)2-4-17(16)31-21(26)29/h2-5,10-11,13H,6-9,12H2,1H3,(H,24,28)	KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	PubMed	n/a	n/a	2.30	n/a	n/a	n/a	n/a	n/a	n/a
Fujisawa Pharmaceutical Co., Ltd. Curated by ChEMBL					Assay Description Inhibitory concentration of total specific binding of [125I]- -PYY to HEK 293 cells transfected with Human NPY-Y5 cDNA (compound prepared by manual s...				Bioorg Med Chem Lett 12: 1171-5 (2002) BindingDB Entry DOI: 10.7270/Q26M365J
					More data for this Ligand-Target Pair
Neuropeptide Y receptor type 5 (Homo sapiens (Human))	BDBM50111654 (1-[2-(5-Chloro-2-oxo-benzothiazol-3-yl)-acetyl]-pi...) Show SMILES COc1ccc(CNC(=O)C2CCN(CC2)C(=O)Cn2c3cc(Cl)ccc3sc2=O)cc1 Show InChI InChI=1S/C23H24ClN3O4S/c1-31-18-5-2-15(3-6-18)13-25-22(29)16-8-10-26(11-9-16)21(28)14-27-19-12-17(24)4-7-20(19)32-23(27)30/h2-7,12,16H,8-11,13-14H2,1H3,(H,25,29)	KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	PubMed	n/a	n/a	2.30	n/a	n/a	n/a	n/a	n/a	n/a
Fujisawa Pharmaceutical Co., Ltd. Curated by ChEMBL					Assay Description Inhibitory concentration of total specific binding of [125I]- -PYY to HEK 293 cells transfected with Human NPY-Y5 cDNA (compound prepared by manual s...				Bioorg Med Chem Lett 12: 1171-5 (2002) BindingDB Entry DOI: 10.7270/Q26M365J
					More data for this Ligand-Target Pair
Neuropeptide Y receptor type 5 (Homo sapiens (Human))	BDBM50111642 (1-[2-(5-Chloro-2-oxo-benzothiazol-3-yl)-acetyl]-pi...) Show SMILES COc1ccc(NC(=O)C2CCN(CC2)C(=O)Cn2c3cc(Cl)ccc3sc2=O)cn1 Show InChI InChI=1S/C21H21ClN4O4S/c1-30-18-5-3-15(11-23-18)24-20(28)13-6-8-25(9-7-13)19(27)12-26-16-10-14(22)2-4-17(16)31-21(26)29/h2-5,10-11,13H,6-9,12H2,1H3,(H,24,28)	KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	PubMed	n/a	n/a	2.60	n/a	n/a	n/a	n/a	n/a	n/a
Fujisawa Pharmaceutical Co., Ltd. Curated by ChEMBL					Assay Description Inhibitory concentration of total specific binding of [125I]- -PYY to HEK 293 cells transfected with Human NPY-Y5 cDNA (compound prepared by manual s...				Bioorg Med Chem Lett 12: 1171-5 (2002) BindingDB Entry DOI: 10.7270/Q26M365J
					More data for this Ligand-Target Pair
Neuropeptide Y receptor type 5 (Homo sapiens (Human))	BDBM50111649 (1-[2-(5-Chloro-2-oxo-benzothiazol-3-yl)-acetyl]-pi...) Show SMILES CCCCCCCCCCNC(=O)C1CCN(CC1)C(=O)Cn1c2cc(Cl)ccc2sc1=O Show InChI InChI=1S/C25H36ClN3O3S/c1-2-3-4-5-6-7-8-9-14-27-24(31)19-12-15-28(16-13-19)23(30)18-29-21-17-20(26)10-11-22(21)33-25(29)32/h10-11,17,19H,2-9,12-16,18H2,1H3,(H,27,31)	KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	PubMed	n/a	n/a	2.60	n/a	n/a	n/a	n/a	n/a	n/a
Fujisawa Pharmaceutical Co., Ltd. Curated by ChEMBL					Assay Description Inhibitory concentration of total specific binding of [125I]- -PYY to HEK 293 cells transfected with the Human NPY-Y5 cDNA (compound prepared by para...				Bioorg Med Chem Lett 12: 1171-5 (2002) BindingDB Entry DOI: 10.7270/Q26M365J
					More data for this Ligand-Target Pair
Neuropeptide Y receptor type 5 (Homo sapiens (Human))	BDBM50111648 (1-[2-(5-Chloro-2-oxo-benzothiazol-3-yl)-acetyl]-pi...) Show SMILES Cc1ccc2nc(NC(=O)C3CCN(CC3)C(=O)Cn3c4cc(Cl)ccc4sc3=O)sc2c1 Show InChI InChI=1S/C23H21ClN4O3S2/c1-13-2-4-16-19(10-13)32-22(25-16)26-21(30)14-6-8-27(9-7-14)20(29)12-28-17-11-15(24)3-5-18(17)33-23(28)31/h2-5,10-11,14H,6-9,12H2,1H3,(H,25,26,30)	KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	PubMed	n/a	n/a	2.80	n/a	n/a	n/a	n/a	n/a	n/a
Fujisawa Pharmaceutical Co., Ltd. Curated by ChEMBL					Assay Description Inhibitory concentration of total specific binding of [125I]- -PYY to HEK 293 cells transfected with the Human NPY-Y5 cDNA (compound prepared by para...				Bioorg Med Chem Lett 12: 1171-5 (2002) BindingDB Entry DOI: 10.7270/Q26M365J
					More data for this Ligand-Target Pair
Neuropeptide Y receptor type 5 (Homo sapiens (Human))	BDBM50111643 (1-[2-(5-Chloro-2-oxo-benzothiazol-3-yl)-acetyl]-pi...) Show SMILES OCCc1ccc(NC(=O)C2CCN(CC2)C(=O)Cn2c3cc(Cl)ccc3sc2=O)cc1 Show InChI InChI=1S/C23H24ClN3O4S/c24-17-3-6-20-19(13-17)27(23(31)32-20)14-21(29)26-10-7-16(8-11-26)22(30)25-18-4-1-15(2-5-18)9-12-28/h1-6,13,16,28H,7-12,14H2,(H,25,30)	KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	PubMed	n/a	n/a	2.90	n/a	n/a	n/a	n/a	n/a	n/a
Fujisawa Pharmaceutical Co., Ltd. Curated by ChEMBL					Assay Description Inhibitory concentration of total specific binding of [125I]- -PYY to HEK 293 cells transfected with Human NPY-Y5 cDNA (compound prepared by manual s...				Bioorg Med Chem Lett 12: 1171-5 (2002) BindingDB Entry DOI: 10.7270/Q26M365J
					More data for this Ligand-Target Pair
Neuropeptide Y receptor type 5 (Homo sapiens (Human))	BDBM50111657 (1-[2-(5-Chloro-2-oxo-benzothiazol-3-yl)-acetyl]-pi...) Show SMILES Cc1cccc(n1)C(O)CNC(=O)C1CCN(CC1)C(=O)Cn1c2cc(Cl)ccc2sc1=O Show InChI InChI=1S/C23H25ClN4O4S/c1-14-3-2-4-17(26-14)19(29)12-25-22(31)15-7-9-27(10-8-15)21(30)13-28-18-11-16(24)5-6-20(18)33-23(28)32/h2-6,11,15,19,29H,7-10,12-13H2,1H3,(H,25,31)	KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	PubMed	n/a	n/a	3.30	n/a	n/a	n/a	n/a	n/a	n/a
Fujisawa Pharmaceutical Co., Ltd. Curated by ChEMBL					Assay Description Tested for the inhibition of [125I]-PYY binding to HEK 293 cells stably expressed with human neuropeptide NPY Y5 receptor at a concentration of 10e-6...				Bioorg Med Chem Lett 12: 1171-5 (2002) BindingDB Entry DOI: 10.7270/Q26M365J
					More data for this Ligand-Target Pair
Neuropeptide Y receptor type 5 (Homo sapiens (Human))	BDBM50110565 (CHEMBL164873 | Naphthalene-1-sulfonic acid (2-{4-[...) Show SMILES COc1ccc2CCCC(Cc2c1)NCC1CCN(CC1)C(=O)CNS(=O)(=O)c1cccc2ccccc12 Show InChI InChI=1S/C30H37N3O4S/c1-37-27-13-12-23-7-4-9-26(18-25(23)19-27)31-20-22-14-16-33(17-15-22)30(34)21-32-38(35,36)29-11-5-8-24-6-2-3-10-28(24)29/h2-3,5-6,8,10-13,19,22,26,31-32H,4,7,9,14-18,20-21H2,1H3	KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	PubMed	n/a	n/a	3.70	n/a	n/a	n/a	n/a	n/a	n/a
Fujisawa Pharmaceutical Co., Ltd. Curated by ChEMBL					Assay Description Inhibition of 125 I-PYY binding to human Neuropeptide Y receptor type 5				Bioorg Med Chem Lett 12: 799-802 (2002) BindingDB Entry DOI: 10.7270/Q2M044R7
					More data for this Ligand-Target Pair
Neuropeptide Y receptor type 5 (Homo sapiens (Human))	BDBM50111655 (1-[2-(5-Chloro-2-oxo-benzothiazol-3-yl)-acetyl]-pi...) Show SMILES Clc1ccc2oc(NC(=O)C3CCN(CC3)C(=O)Cn3c4cc(Cl)ccc4sc3=O)nc2c1 Show InChI InChI=1S/C22H18Cl2N4O4S/c23-13-1-3-17-15(9-13)25-21(32-17)26-20(30)12-5-7-27(8-6-12)19(29)11-28-16-10-14(24)2-4-18(16)33-22(28)31/h1-4,9-10,12H,5-8,11H2,(H,25,26,30)	KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem	PubMed	n/a	n/a	3.80	n/a	n/a	n/a	n/a	n/a	n/a
Fujisawa Pharmaceutical Co., Ltd. Curated by ChEMBL					Assay Description Inhibitory concentration of total specific binding of [125I]- -PYY to HEK 293 cells transfected with Human NPY-Y5 cDNA (compound prepared by manual s...				Bioorg Med Chem Lett 12: 1171-5 (2002) BindingDB Entry DOI: 10.7270/Q26M365J
					More data for this Ligand-Target Pair
Neuropeptide Y receptor type 5 (Homo sapiens (Human))	BDBM50111652 (1-[2-(5-Chloro-2-oxo-benzothiazol-3-yl)-acetyl]-pi...) Show SMILES Clc1ccc2sc(=O)n(CC(=O)N3CCC(CC3)C(=O)Nc3ccccc3)c2c1 Show InChI InChI=1S/C21H20ClN3O3S/c22-15-6-7-18-17(12-15)25(21(28)29-18)13-19(26)24-10-8-14(9-11-24)20(27)23-16-4-2-1-3-5-16/h1-7,12,14H,8-11,13H2,(H,23,27)	KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	PubMed	n/a	n/a	4.40	n/a	n/a	n/a	n/a	n/a	n/a
Fujisawa Pharmaceutical Co., Ltd. Curated by ChEMBL					Assay Description Tested for the inhibition of [125I]-PYY binding to HEK 293 cells stably expressed with human neuropeptide NPY Y5 receptor				Bioorg Med Chem Lett 12: 1171-5 (2002) BindingDB Entry DOI: 10.7270/Q26M365J
					More data for this Ligand-Target Pair
Neuropeptide Y receptor type 5 (Homo sapiens (Human))	BDBM50111655 (1-[2-(5-Chloro-2-oxo-benzothiazol-3-yl)-acetyl]-pi...) Show SMILES Clc1ccc2oc(NC(=O)C3CCN(CC3)C(=O)Cn3c4cc(Cl)ccc4sc3=O)nc2c1 Show InChI InChI=1S/C22H18Cl2N4O4S/c23-13-1-3-17-15(9-13)25-21(32-17)26-20(30)12-5-7-27(8-6-12)19(29)11-28-16-10-14(24)2-4-18(16)33-22(28)31/h1-4,9-10,12H,5-8,11H2,(H,25,26,30)	KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem	PubMed	n/a	n/a	4.70	n/a	n/a	n/a	n/a	n/a	n/a
Fujisawa Pharmaceutical Co., Ltd. Curated by ChEMBL					Assay Description Inhibitory concentration of total specific binding of [125I]- -PYY to HEK 293 cells transfected with the Human NPY-Y5 cDNA (compound prepared by para...				Bioorg Med Chem Lett 12: 1171-5 (2002) BindingDB Entry DOI: 10.7270/Q26M365J
					More data for this Ligand-Target Pair
Neuropeptide Y receptor type 5 (Homo sapiens (Human))	BDBM50111651 (1-[2-(5-Chloro-2-oxo-benzothiazol-3-yl)-acetyl]-pi...) Show SMILES Cc1cc(O)ccc1NC(=O)C1CCN(CC1)C(=O)Cn1c2cc(Cl)ccc2sc1=O Show InChI InChI=1S/C22H22ClN3O4S/c1-13-10-16(27)3-4-17(13)24-21(29)14-6-8-25(9-7-14)20(28)12-26-18-11-15(23)2-5-19(18)31-22(26)30/h2-5,10-11,14,27H,6-9,12H2,1H3,(H,24,29)	KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	PubMed	n/a	n/a	4.70	n/a	n/a	n/a	n/a	n/a	n/a
Fujisawa Pharmaceutical Co., Ltd. Curated by ChEMBL					Assay Description Inhibitory concentration of total specific binding of [125I]- -PYY to HEK 293 cells transfected with Human NPY-Y5 cDNA (compound prepared by manual s...				Bioorg Med Chem Lett 12: 1171-5 (2002) BindingDB Entry DOI: 10.7270/Q26M365J
					More data for this Ligand-Target Pair
Neuropeptide Y receptor type 5 (Homo sapiens (Human))	BDBM50111653 (1-[2-(5-Chloro-2-oxo-benzothiazol-3-yl)-acetyl]-pi...) Show SMILES NS(=O)(=O)c1ccc(CCNC(=O)C2CCN(CC2)C(=O)Cn2c3cc(Cl)ccc3sc2=O)cc1 Show InChI InChI=1S/C23H25ClN4O5S2/c24-17-3-6-20-19(13-17)28(23(31)34-20)14-21(29)27-11-8-16(9-12-27)22(30)26-10-7-15-1-4-18(5-2-15)35(25,32)33/h1-6,13,16H,7-12,14H2,(H,26,30)(H2,25,32,33)	KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	PubMed	n/a	n/a	6.10	n/a	n/a	n/a	n/a	n/a	n/a
Fujisawa Pharmaceutical Co., Ltd. Curated by ChEMBL					Assay Description Inhibitory concentration of total specific binding of [125I]- -PYY to HEK 293 cells transfected with the Human NPY-Y5 cDNA (compound prepared by para...				Bioorg Med Chem Lett 12: 1171-5 (2002) BindingDB Entry DOI: 10.7270/Q26M365J
					More data for this Ligand-Target Pair
Neuropeptide Y receptor type 5 (Homo sapiens (Human))	BDBM50111653 (1-[2-(5-Chloro-2-oxo-benzothiazol-3-yl)-acetyl]-pi...) Show SMILES NS(=O)(=O)c1ccc(CCNC(=O)C2CCN(CC2)C(=O)Cn2c3cc(Cl)ccc3sc2=O)cc1 Show InChI InChI=1S/C23H25ClN4O5S2/c24-17-3-6-20-19(13-17)28(23(31)34-20)14-21(29)27-11-8-16(9-12-27)22(30)26-10-7-15-1-4-18(5-2-15)35(25,32)33/h1-6,13,16H,7-12,14H2,(H,26,30)(H2,25,32,33)	KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	PubMed	n/a	n/a	9	n/a	n/a	n/a	n/a	n/a	n/a
Fujisawa Pharmaceutical Co., Ltd. Curated by ChEMBL					Assay Description Inhibitory concentration of total specific binding of [125I]- -PYY to HEK 293 cells transfected with the Human NPY-Y5 cDNA (compound prepared by para...				Bioorg Med Chem Lett 12: 1171-5 (2002) BindingDB Entry DOI: 10.7270/Q26M365J
					More data for this Ligand-Target Pair
Neuropeptide Y receptor type 5 (Homo sapiens (Human))	BDBM50111648 (1-[2-(5-Chloro-2-oxo-benzothiazol-3-yl)-acetyl]-pi...) Show SMILES Cc1ccc2nc(NC(=O)C3CCN(CC3)C(=O)Cn3c4cc(Cl)ccc4sc3=O)sc2c1 Show InChI InChI=1S/C23H21ClN4O3S2/c1-13-2-4-16-19(10-13)32-22(25-16)26-21(30)14-6-8-27(9-7-14)20(29)12-28-17-11-15(24)3-5-18(17)33-23(28)31/h2-5,10-11,14H,6-9,12H2,1H3,(H,25,26,30)	KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	PubMed	n/a	n/a	10	n/a	n/a	n/a	n/a	n/a	n/a
Fujisawa Pharmaceutical Co., Ltd. Curated by ChEMBL					Assay Description Inhibitory concentration of total specific binding of [125I]- -PYY to HEK 293 cells transfected with Human NPY-Y5 cDNA (compound prepared by manual s...				Bioorg Med Chem Lett 12: 1171-5 (2002) BindingDB Entry DOI: 10.7270/Q26M365J
					More data for this Ligand-Target Pair
Neuropeptide Y receptor type 5 (Homo sapiens (Human))	BDBM50110573 (3-Chloro-N-[2-(4-{[(1-hydroxy-7-methoxy-1,2,3,4-te...) Show SMILES COc1ccc2CCCC(O)(CNCC3CCN(CCNS(=O)(=O)c4cccc(Cl)c4C)CC3)c2c1 Show InChI InChI=1S/C27H38ClN3O4S/c1-20-25(28)6-3-7-26(20)36(33,34)30-13-16-31-14-10-21(11-15-31)18-29-19-27(32)12-4-5-22-8-9-23(35-2)17-24(22)27/h3,6-9,17,21,29-30,32H,4-5,10-16,18-19H2,1-2H3	KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	PubMed	n/a	n/a	11	n/a	n/a	n/a	n/a	n/a	n/a
Fujisawa Pharmaceutical Co., Ltd. Curated by ChEMBL					Assay Description Inhibition of 125 I-PYY binding to human Neuropeptide Y receptor type 5				Bioorg Med Chem Lett 12: 799-802 (2002) BindingDB Entry DOI: 10.7270/Q2M044R7
					More data for this Ligand-Target Pair
Neuropeptide Y receptor type 5 (Homo sapiens (Human))	BDBM50110572 (CHEMBL167860 | N-[2-(4-{[(1-Hydroxy-7-methoxy-1,2,...) Show SMILES COc1ccc2CCCC(O)(CNCC3CCN(CCNS(=O)(=O)c4cccc(C)c4)CC3)c2c1 Show InChI InChI=1S/C27H39N3O4S/c1-21-5-3-7-25(17-21)35(32,33)29-13-16-30-14-10-22(11-15-30)19-28-20-27(31)12-4-6-23-8-9-24(34-2)18-26(23)27/h3,5,7-9,17-18,22,28-29,31H,4,6,10-16,19-20H2,1-2H3	KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	PubMed	n/a	n/a	13	n/a	n/a	n/a	n/a	n/a	n/a
Fujisawa Pharmaceutical Co., Ltd. Curated by ChEMBL					Assay Description Inhibition of 125 I-PYY binding to human Neuropeptide Y receptor type 5				Bioorg Med Chem Lett 12: 799-802 (2002) BindingDB Entry DOI: 10.7270/Q2M044R7
					More data for this Ligand-Target Pair

Displayed 1 to 50 (of 176 total )  |  Next  |  Last  >>

Jump to: